Knight School— Get SMMART: Challenges, opportunities, and new directions

When
November 19, 2019
7 p.m. to 8:30 p.m.
Where
2720 S. Moody Avenue
Portland, Oregon 97201
Contact Information
Knight Cancer Institute
Zahi Mitri, M.D. talking with another person
Zahi Mitri, M.D., a medical oncologist is leading the SMMART trial of a targeted drug combination against metastatic, triple negative breast cancer.

At the OHSU Knight Cancer Institute, researchers have built a first-of-its-kind platform designed to find combinations of drugs that can stop tumors before they adapt and become drug-resistant. In-depth tracking of each patient’s cancer over time makes it possible to adjust targeted drug combinations to stay ahead of cancer’s ability to evolve. The platform is called SMMART™ (Serial Measurements of Molecular and Architectural Responses to Therapy). Join us as we explore what makes this approach unique, how it’s working, and what’s next.

Learn more, register